You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Rare disease
Ophthalmic complication of pityriasis rubra pilaris
  1. Malik Moledina1,
  2. Simon Davison2 and
  3. Adeela Malik1
  1. 1Southend University Hospital NHS Foundation Trust, Southend-on-Sea, UK
  2. 2Barking Havering and Redbridge University Hospitals NHS Trust, Romford, London, UK
  1. Correspondence to Dr Malik Moledina; malik123{at}outlook.com

Abstract

Pityriasis rubra pilaris (PRP) is a rare dermatological condition which may present with ocular manifestations. We report a case of recurrent cicatricial ectropion (CE) with topical beta-blocker use in the rare dermatological condition PRP. The patient underwent release of scar tissue, lateral tarsal strip and full-thickness supraclavicular skin graft for CE following immunosuppression with methotrexate for 3 months. Postoperatively, CE recurred, with skin graft shrinkage and resumption of periocular disease activity, 8 weeks following the introduction of topical timolol. The patient was referred for further immunosuppression and substitution of timolol before consideration for further surgery. PRP has a variety of potential ocular complications. Surgery has a high risk of recurrence and should be performed when the overall disease is quiescent and drugs, which could trigger reactivation, have been discontinued and/or substituted. Skin grafts should be oversized to off-set shrinkage.

  • Eye
  • Head and neck surgery
  • Plastic and reconstructive surgery
  • Ophthalmology
  • Dermatology

https://doi.org/10.1136/bcr-2023-256445

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors All authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content. All authors have been involved in the planning, conduct, reporting, conception and design, acquisition of data or analysis and interpretation of data. All authors gave final approval of the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.